A neural mechanism for nonconscious activation of conditioned placebo and nocebo responses

Cerebral Cortex

Volumn 25, Issue 10, 2015, Pages 3903-3910

  Jensen, Karin B ^a,b,d   Kaptchuk, Ted J ^b   Chen, Xiaoyan ^a   Kirsch, Irving ^b,c   Ingvar, Martin ^d   Gollub, Randy L ^a,b   Kong, Jian ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amygdala; Conditioning; Nocebo effect; Placebo effect; Subliminal perception

Indexed keywords

PLACEBO;

ADULT; AMYGDALOID NUCLEUS; ANALGESIA; ARTICLE; AWARENESS; BRAIN FUNCTION; CONDITIONED REFLEX; CONSCIOUSNESS; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; NERVE TRACT; NOCEBO EFFECT; NORMAL HUMAN; ORBITAL CORTEX; PAIN; PLACEBO EFFECT; PRIORITY JOURNAL; REWARD; THALAMUS; AMYGDALA; ASSOCIATION; BRAIN; BRAIN MAPPING; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN MEASUREMENT; PERCEPTION; PHYSIOLOGY; PREFRONTAL CORTEX; SUBLIMINAL STIMULATION; YOUNG ADULT;

ADULT; AMYGDALA; AWARENESS; BRAIN; BRAIN MAPPING; CONDITIONING, CLASSICAL; CONSCIOUSNESS; CUES; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NOCEBO EFFECT; PAIN MEASUREMENT; PAIN PERCEPTION; PERCEPTUAL MASKING; PLACEBO EFFECT; PREFRONTAL CORTEX; SUBLIMINAL STIMULATION; THALAMUS; YOUNG ADULT;

EID: 84948696405     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu275     Document Type: Article

References (51)

1. Amanzio M, Benedetti F. 1999. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci. 19:484-494.
2. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. 2006. The biochemical and neuroendocrine bases of the hyperalgesic no-cebo effect. J Neurosci. 26:12014-12022.
3. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. 2003. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 23:4315-4323.
4. Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C. 2006. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain. 120:8-15.
5. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I. 2011. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med. 3:70ra14.
6. Breiter HC, Etcoff NL, Whalen PJ, Kennedy WA, Rauch SL, Buckner RL, Strauss MM, Hyman SE, Rosen BR. 1996. Response and habituation of the human amygdala during visual processing of facial expression. Neuron. 17:875-887.
7. Buchel C, Geuter S, Sprenger C, Eippert F. 2014. Placebo analgesia: a predictive coding perspective. Neuron. 81:1223-1239.
8. Carlsson K, Petersson KM, Lundqvist D, Karlsson A, Ingvar M, Öhman A. 2004. Fear and the amygdala: manipulation of awareness generates differential cerebral responses to phobic and fear-relevant (but nonfeared) stimuli. Emotion. 4:340-353.
9. Colloca L, Benedetti F. 2009. Placebo analgesia induced by social observational learning. Pain. 144:28-34.
10. Colloca L, Sigaudo M, Benedetti F. 2008. The role of learning in no-cebo and placebo effects. Pain. 136:211-218.
11. Custers R, Aarts H. 2010. The unconscious will: how the pursuit of goals operates outside of conscious awareness. Science. 329:47-50.
12. Dijksterhuis A, Aarts H, Smith PK. 2005. The powerof the subliminal: on subliminal persuasion and other potential applications. In: The New Unconscious-Social Cognition and Social Neuroscience. New York: Oxford University Press.
13. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C. 2009. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 63:533-543.
14. Esteves F, Parra C, Dimberg U, Ohman A. 1994. Nonconscious associative learning: pavlovian conditioning of skin conductance responses to masked fear-relevant facial stimuli. Psychophysiology. 31:375-385.
15. Jensen KB, Kaptchuk TJ, Kirsch I, Raicek J, Lindstrom KM, Berna C, Gollub RL, Ingvar M, Kong J. 2012. Nonconscious activation of placebo and nocebo pain responses. PNAS. 109:15959-15964.
16. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med. 5:e45.
17. Kirsch I, Kong J, Sadler P, Spaeth R, Cook A, Kaptchuk TJ, Gollub R. 2014. Expectancy and conditioning in placebo analgesia: separate or connected processes? Psychol Conscious: Theory Res Pract. 1:51-59.
18. Kirsch I, Lynn SJ, Vigorito M, Miller RR. 2004. The role of cognition in classical and operant conditioning. J Clin Psychol. 60:369-392.
19. Kong J, Gollub RL, Polich G, Kirsch I, LaViolette P, Vangel M, Rosen B, Kaptchuk TJ. 2008. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic no-cebo effect. J Neurosci. 28:13354-13362.
20. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, Kaptchuk TJ. 2006. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci. 26:381-388.
21. Kong J, Jensen K, Loiotile R, Cheetham A, Wey HY, Tan Y, Rosen B, Smoller JW, Kaptchuk TJ, Gollub RL. 2013. Functional connectivity of the frontoparietal network predicts cognitive modulation of pain. Pain. 154:459-467.
22. Kouider S, Dehaene S. 2007. Levels of processing during non-conscious perception: a critical review of visual masking. Philos Trans R Soc Lond B Biol Sci. 362:857-875.
23. Kringelbach M. 2005. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci. 6:691-702.
24. LeDoux JE. 2000. Emotion circuits in the brain. Ann Rev Neurosci. 23:155-184.
25. Leknes S, Lee M, Berna C, Andersson J, Tracey I. 2011. Relief as a reward: hedonic and neural responses to safety from pain. PLoS One. 6:e17870.
26. Mesulam MM. 1998. From sensation to cognition. Brain. 121:1013-1052.
27. Mobbs D, Marchant JL, Hassabis D, Seymour B, Tan G, Gray M, Petrovic P, Dolan RJ, Frith CD. 2009. From threat to fear: the neural organization of defensive fear systems in humans. J Neurosci. 29:12236-12243.
28. Montgomery GH, Kirsch I. 1997. Classical conditioning and the placebo effect. Pain. 72:107-113.
29. Morris JS, Ohman A, Dolan RJ. 1998. Conscious and unconscious emotional learning in the human amygdala. Nature. 393:467-470.
30. O'Doherty JP. 2007. Lights, camembert, action! The role of human orbitofrontal cortex in encoding stimuli, rewards, and choices. Ann N Y Acad Sci. 1121:254-272.
31. O'Doherty JP, Deichmann R, Critchley HD, Dolan RJ. 2002. Neural responses during anticipation of a primary taste reward. Neuron. 33:815-826.
32. O'Doherty JP, Dolan RJ. 2006. The role of human orbitofrontal cortex in reward prediction and behavioural choice: insights from neuroimaging. In: Zald D, Rauch SL, editors. The Orbitofrontal Cortex. Oxford: Oxford University Press.
33. Öhman A, Carlsson K, Lundqvist D, Ingvar M. 2007. Onthe unconscious subcortical origin of human fear. Physiol Behav. 92:180-185.
34. Pessiglione M, Petrovic P, Daunizeau J, Palminteri S, Dolan R, Frith C. 2008. Subliminal instrumental conditioning demonstrated in the human brain. Neuron. 59:561-567.
35. Pessiglione M, Schmidt L, Draganski B, Kalisch R, Lau H, Dolan RJ, Frith CD. 2007. How the brain translates money into force: a neuroimaging study of subliminal motivation. Science. 316:904-906.
36. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M.2005. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron. 46:957-969.
37. Petrovic P, Kalso E, Petersson KM, Andersson J, Fransson P, Ingvar M. 2010. A prefrontal non-opioid mechanism in placebo analgesia. Pain. 150:59-65.
38. Phelps E. 2005. The interaction of emotion and cognition: the relation between the human amygdala and cognitive awareness. In: Hassin RR, Uleman JS, Bargh JA, editors. The New Unconscious-Social Cognition and Social Neuroscience. New York: Oxford University Press.
39. Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R, Matthews PM, Rawlins JNP, Tracey I. 2001. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci. 21:9896-9903.
40. Rolls ET. 2000. The orbitofrontal cortex and reward. Cereb Cortex. 10:284-294.
41. Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC. 2009. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci. 29:4882-4887.
42. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta J-K. 2009. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron. 55: 325-336.
43. Stewart-Williams S, Podd J. 2004. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull. 130:324-340.
44. Thorpe SJ, Rolls ET, Maddison S. 1983. The orbitofrontal cortex: neuronal activity in the behaving monkey. Exp Brain Res. 49:93-115.
45. Todorov A. 2011. Evaluating faces on social dimensions. In: Todorov A, Fiske S, Prentice D, editors. Social Neuroscience: Toward Understanding the Underpinnings of the Social Mind. Oxford: Oxford University Press.
46. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD. 2004. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science. 303:1162-1167.
47. Watson A, El-Deredy W, Bentley DE, Vogt BA, Jones AKP. 2006. Categories of placebo response in the absence of site-specific expectation of analgesia. Pain. 126:115-122.
48. Watson A, El-Deredy W, Vogt BA, Jones AKP. 2007. Placebo analgesiaisnot duetocomplianceorhabituation:EEGandbe-havioural evidence. Neuro Report. 18:771-775.
49. Wechsler ME, Kelley JM, Boyd IO, Dutile S, Marigowda G, Kirsch I, Israel E, Kaptchuk TJ. 2011. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med. 365:119-126.
50. Whalen PJ, Rauch SL, Etcoff NL, McInerney SC, Lee MB, Jenike MA. 1998. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci. 18:411-418.
51. Zhang YQ, Tang JS, Yuan B, Jia H. 1997. Inhibitory effects of electrically evoked activation of ventrolateral orbital cortex on the tail-flick reflex are mediated by periaqueductal gray in rats. Pain. 72:127-135.